CD4 and neoplasm: Interestingly, a study published by the other group showed that the depletion of CD8 cells significantly reduced the mouse survival when treated with doxorubicin, while CD4 depletion did not, which demonstrated that the reduced tumor growth is CD8+ T cell dependent [43].